Projects per year
Fingerprint
Dive into the research topics where Richard Geoffrey Vile is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Re-purposing Oncolytic Virotherapy to Re-invigorate CAR T Cell Therapy for Solid Tumors.
Vile, R. G. (PI)
12/1/22 → 11/30/25
Project: Research project
-
Mayo Clinic Hepatobiliary SPORE
Mc Niven, M. M. A. (PI), Alberts, S. R. (CoPI), Wang, C. C. (CoPI), Gores, G. J. (CoPI), Leof, E. B. (CoPI), Roberts, L. R. (CoPI), Mandrekar, S. J. (CoPI), Smoot, R. (CoPI), Simon, S. M. (CoPI), Torbenson, M. (CoPI), Vile, R. G. (CoPI) & Yin, V. (CoPI)
9/10/18 → 8/31/25
Project: Research project
-
Characterizing the role of CSDE1 as a critical co-factor for VSV replication.
Vile, R. G. (PI)
National Institute of Allergy and Infectious Diseases
3/20/23 → 2/28/25
Project: Research project
-
Novel Strategies to Treat Diffuse Midline Glioma with CAR T Cell Therapy
Vile, R. G. (PI)
6/1/21 → 5/31/23
Project: Research project
-
Project 4: Immunovirotherapy
Vile, R. G. (PI) & Vile, R. R. G. (PI)
9/1/18 → 8/31/23
Project: Research project
-
APOBEC3B expression in 293T viral producer cells drives mutations in chimeric antigen receptors and reduces CAR T cell efficacy
Swanson, J., Tonne, J., Sangsuwannukul, T., Thompson, J., Kendall, B., Liseth, O., Metko, M. & Vile, R., Dec 19 2024, In: Molecular Therapy Oncology. 32, 4, 200873.Research output: Contribution to journal › Article › peer-review
Open Access -
Expression of tumor antigens within an oncolytic virus enhances the anti-tumor T cell response
Webb, M. J., Sangsuwannukul, T., van Vloten, J., Evgin, L., Kendall, B., Tonne, J., Thompson, J., Metko, M., Moore, M., Chiriboga Yerovi, M. P., Olin, M., Borgatti, A., McNiven, M., Monga, S. P. S., Borad, M. J., Melcher, A., Roberts, L. R. & Vile, R., Dec 2024, In: Nature communications. 15, 1, 5442.Research output: Contribution to journal › Article › peer-review
Open Access -
Intranasal Prime–Boost with Spike Vectors Generates Antibody and T-Cell Responses at the Site of SARS-CoV-2 Infection
Metko, M., Tonne, J., Veliz Rios, A., Thompson, J., Mudrick, H., Masopust, D., Diaz, R. M., Barry, M. A. & Vile, R. G., Oct 2024, In: Vaccines. 12, 10, 1191.Research output: Contribution to journal › Article › peer-review
Open Access -
Smoldering oncolysis by foamy virus carrying CD19 as a CAR target escapes CAR T detection by genomic modification
Tonne, J. M., Budzik, K., Carrasco, T. F., Ebbert, L., Thompson, J., Nace, R., Kendall, B., Diaz, R. M., Russell, S. J. & Vile, R. G., Sep 19 2024, In: Molecular Therapy Oncology. 32, 3, 200852.Research output: Contribution to journal › Article › peer-review
Open Access -
Anti–PD-1 and Extended Half-life IL2 Synergize for Treatment of Murine Glioblastoma Independent of Host MHC Class I Expression
Tritz, Z. P., Ayasoufi, K., Wolf, D. M., Owens, C. A., Malo, C. S., Himes, B. T., Fain, C. E., Goddery, E. N., Yokanovich, L. T., Jin, F., Hansen, M. J., Parney, I. F., Wang, C., Moynihan, K. D., Irvine, D. J., Wittrup, K. D., Diaz Marcano, R. M., Vile, R. G. & Johnson, A. J., Jun 1 2023, In: Cancer Immunology Research. 11, 6, p. 763-766 4 p.Research output: Contribution to journal › Article › peer-review
Open Access